Healome Therapeutics
Latest round
- Seed
Last raised
- Oct 2025
Total raised
- $2.7M
Investors
- 4
About Healome Therapeutics
Healome Therapeutics Ltd, founded in 2021, is dedicated to innovative ocular drug delivery solutions.Healome Therapeutics specializes in the development of innovative ocular drug delivery systems. The company focuses on its proprietary eye drop matrix technology, which initially behaves like a liquid and restructures to create a clear, lubricating, and protective matrix on the ocular surface. This addresses the limitations of conventional eye drops, which clear quickly from the surface, enhancing therapeutic effects and longevity. Healome's products target a range of ocular surface conditions, delivering both small molecules and complex biologics to individuals with ocular diseases and healthcare providers seeking improved treatment options.Healome Therapeutics generates revenue through the commercialization of its ocular drug delivery products. The company engages in B2B transactions, partnering with healthcare providers and pharmaceutical companies who purchase its eye drop matrix technology for clinical use. Although specific pricing information is not disclosed, the pricing structure reflects the advanced formulation and delivery capabilities of Healome's products. The company aims to expand its market presence by launching new products designed to enhance ocular health and targeting regions with increasing demand for advanced eye care solutions.
Who invested in Healome Therapeutics
4 investors across 1 round
See all investors in Healome Therapeutics
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Seed
Oct 15, 2025
Amount
$2.7M
Investors
Questions about Healome Therapeutics
Who invested in Healome Therapeutics?
Healome Therapeutics has 4 investors on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Healome Therapeutics raised?
Healome Therapeutics has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did Healome Therapeutics last raise money?
Healome Therapeutics's most recent round on record is a Seed, in Oct 2025.
What does Healome Therapeutics do?
Healome Therapeutics Ltd, founded in 2021, is dedicated to innovative ocular drug delivery solutions.
Where is Healome Therapeutics headquartered?
Healome Therapeutics is headquartered in Birmingham, UK.
Which VCs invest in companies like Healome Therapeutics?
Among active investors with capital left to deploy, Index Ventures, Forbion, European Investment Bank and Balderton Capital back pharmaceuticals companies at Healome Therapeutics's stage. Their profiles are linked below.
VCs backing pharmaceuticals startups at Seed
Raising like Healome Therapeutics? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.